Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Berger

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Data in Brief|December 25, 2019
Structural characterization of an ionic liquid in bulk and in nano-confined environment using data from MD simulationsNataša Vučemilović-Alagić, Radha D Banhatti, Robert Stepić, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2013
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adultsPeter J Ruane, Edwin DeJesus, Daniel Berger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2010
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapyTaran Paulsen Hellebust, Christian Kirisits, Daniel Berger, et al.
Acta Oncologica (Stockholm, Sweden)|August 21, 2013
Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapyMaximilian P Schmid, Elena Fidarova, Richard Pötter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2010
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extensionJulian Falutz, Diane Potvin, Jean-Claude Mamputu, et al.
Microbial Cell Factories|April 15, 2023
Discovery of novel amino acid production traits by evolution of synthetic co-culturesRico Zuchowski, Simone Schito, Friederike Neuheuser, et al.
Lancet (London, England)|July 10, 2007
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trialJosé Valdez Madruga, Daniel Berger, Marilyn McMurchie, et al.
Annals of Internal Medicine|September 11, 2003
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trialKathleen Squires, Anton L Pozniak, Gerald Pierone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2014
Four years with FALCON - an ESTRO educational project: achievements and perspectivesJesper Grau Eriksen, Carl Salembier, Sofia Rivera, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2019
Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcomeUmesh Mahantshetty, Alina Sturdza, Pushpa Naga Ch, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Data in Brief|December 25, 2019
Structural characterization of an ionic liquid in bulk and in nano-confined environment using data from MD simulationsNataša Vučemilović-Alagić, Radha D Banhatti, Robert Stepić, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2013
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adultsPeter J Ruane, Edwin DeJesus, Daniel Berger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 2010
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapyTaran Paulsen Hellebust, Christian Kirisits, Daniel Berger, et al.
Acta Oncologica (Stockholm, Sweden)|August 21, 2013
Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapyMaximilian P Schmid, Elena Fidarova, Richard Pötter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2010
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extensionJulian Falutz, Diane Potvin, Jean-Claude Mamputu, et al.
Microbial Cell Factories|April 15, 2023
Discovery of novel amino acid production traits by evolution of synthetic co-culturesRico Zuchowski, Simone Schito, Friederike Neuheuser, et al.
Lancet (London, England)|July 10, 2007
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trialJosé Valdez Madruga, Daniel Berger, Marilyn McMurchie, et al.
Annals of Internal Medicine|September 11, 2003
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trialKathleen Squires, Anton L Pozniak, Gerald Pierone, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2014
Four years with FALCON - an ESTRO educational project: achievements and perspectivesJesper Grau Eriksen, Carl Salembier, Sofia Rivera, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2019
Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcomeUmesh Mahantshetty, Alina Sturdza, Pushpa Naga Ch, et al.
Pageof 13